Assignee
BERGMANN ANDREAS
DE27 patents
Top patents by PatentIndex Score
US8507210B2Aug 13, 2013
Detection of bacterial infections in subjects suffering from dyspnea
BERGMANN ANDREAS31 citations92
US8501415B2Aug 6, 2013
Identification of TSH receptor autoantibodies using affinity-purified antibodies
BERGMANN ANDREAS34 citations90
US9261516B2Feb 16, 2016
Diagnosis and risk stratification using NT-proET-1
BERGMANN ANDREAS8 citations84
US8450463B2May 28, 2013
Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
BERGMANN ANDREAS9 citations84
US8436135B2May 7, 2013
Diagnosis and risk stratification by determining the marker CT-proADM
BERGMANN ANDREAS5 citations84
US8124366B2Feb 28, 2012
Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
BERGMANN ANDREAS9 citations84
US8906857B2Dec 9, 2014
Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
BERGMANN ANDREAS7 citations83
US8691512B2Apr 8, 2014
Method for the detection of sepsis by determining peptide prohormone levels
BERGMANN ANDREAS8 citations83
US8465941B2Jun 18, 2013
Procalcitonin-based diagnosis of infections or inflammatory diseases of the respiratory tract in a patient with heart failure
BERGMANN ANDREAS14 citations83
US8252544B2Aug 28, 2012
Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients
BERGMANN ANDREAS13 citations83
US9229013B2Jan 5, 2016
Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction
BERGMANN ANDREAS10 citations82
US8524463B2Sep 3, 2013
Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP
BERGMANN ANDREAS10 citations82
US8183004B2May 22, 2012
Determination of short-chain SRL alcohol dehydrogenase (DHRS4) as a biomarker for inflammations and infections
BERGMANN ANDREAS17 citations82
US8916388B2Dec 23, 2014
In vitro multiparameter determination method for the diagnosis and early diagnosis of neurodegenerative disorders
BERGMANN ANDREAS8 citations81
US9885709B2Feb 6, 2018
Determination of a midregional proadrenomedullin partial peptide in biological fluids for diagnostic purposes, and immunoassays for carrying out such a determination
BERGMANN ANDREAS2 citations73
US8691595B2Apr 8, 2014
Method for detecting analytes
BERGMANN ANDREAS5 citations73
US8647830B2Feb 11, 2014
Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease
BERGMANN ANDREAS5 citations72
US8501485B2Aug 6, 2013
Risk stratification for acute coronary syndrome by determining copeptin
BERGMANN ANDREAS4 citations72
US8426180B2Apr 23, 2013
Use of carbamoyl phosphate synthetase 1 (CPS) as a humoral biomarker for the diagnosis of tumour diseases and chronic inflammatory intestinal diseases
BERGMANN ANDREAS3 citations63
US8252548B2Aug 28, 2012
In vitro method for the detection of early-stage liver damage
BERGMANN ANDREAS3 citations61
US8298784B2Oct 30, 2012
In vitro procedure for diagnosis and early diagnosis of neurodegenerative diseases
BERGMANN ANDREAS5 citations60
US8735079B2May 27, 2014
Method for risk stratification in stable coronary artery disease
BERGMANN ANDREAS3 citations59
US9046532B2Jun 2, 2015
Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
BERGMANN ANDREAS0 citations52
US9188591B2Nov 17, 2015
Use of precursors of tachykinins and/or their fragments in medical diagnostic
BERGMANN ANDREAS1 citations51
US8158368B2Apr 17, 2012
Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II
BERGMANN ANDREAS1 citations51
US9040670B2May 26, 2015
Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
BERGMANN ANDREAS0 citations49
US9829494B2Nov 28, 2017
Methods of treatment using ADM antibodies
BERGMANN ANDREAS0 citations40